Expression of MATH1, a marker of cerebellar granule cell progenitors, identifies different medulloblastoma sub-types

Neuroscience Letters

Volumn 370, Issue 2-3, 2004, Pages 180-185

  Salsano, Ettore ^a   Pollo, Bianca ^b   Eoli, Marica ^b   Giordana, Maria Teresa ^c   Finocchiaro, Gaetano ^a  

^a Dept Exp Neurosci and Diagnostics   (Italy)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

BIRC5; MATH1; Medulloblastomas; PEDF; Real time PCR; TRKC

Indexed keywords

APOPTOSIS INHIBITOR; BIRC 5 PROTEIN; MARKER; MATH 1 PROTEIN; MESSENGER RNA; NEUROTROPHIN 3; PIGMENT EPITHELIUM DERIVED FACTOR; PROTEIN; SURVIVIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALLELIC IMBALANCE; ARTICLE; ASSAY; CELL DIFFERENTIATION; CEREBELLUM; CEREBELLUM VERMIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; GRANULE CELL; HUMAN; HUMAN TISSUE; MALIGNANT NEOPLASTIC DISEASE; MEDULLOBLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; SURVIVAL; TUMOR LOCALIZATION; UPREGULATION;

ADOLESCENT; ADULT; AGED; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CEREBELLUM; EYE PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MEDULLOBLASTOMA; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; NERVE GROWTH FACTORS; NEURONS; RECEPTOR, TRKC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SERPINS; STEM CELLS; TRANSCRIPTION FACTORS;

EID: 5644266355     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.08.053     Document Type: Article

References (53)

1. H. Abraham, T. Tornoczky, G. Kosztolanyi, and L. Seress Cell formation in the cortical layers of the developing human cerebellum Int. J. Dev. Neurosci. 19 2001 53 62
2. D.C. Altieri Survivin, versatile modulation of cell division and apoptosis in cancer Oncogene 22 2003 8581 8589
3. D.C. Altieri Validating survivin as a cancer therapeutic target Nat. Rev. Cancer 3 2003 46 54
4. T. Araki, T. Taniwaki, S.P. Becerra, G.J. Chader, and J.P. Schwartz Pigment epithelium-derived factor (PEDF) differentially protects immature but not mature cerebellar granule cells against apoptotic cell death J. Neurosci. Res. 53 1998 7 15
5. J. Aruga, T. Tohmonda, S. Homma, and K. Mikoshiba Zic1 promotes the expansion of dorsal neural progenitors in spinal cord by inhibiting neuronal differentiation Dev. Biol. 244 2002 329 341
6. N. Ben-Arie, H.J. Bellen, D.L. Armstrong, A.E. McCall, P.R. Gordadze, Q. Guo, M.M. Matzuk, and H.Y. Zoghbi Math1 is essential for genesis of cerebellar granule neurons Nature 390 1997 169 172
7. J.A. Biegel, C.D. Burk, F.G. Barr, and B.S. Emanuel Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors Cancer Res. 52 1992 3391 3395
8. S.H. Bigner, R.E. McLendon, H. Fuchs, P.E. McKeever, and H.S. Friedman Chromosomal characteristics of childhood brain tumors Cancer Genet. Cytogenet. 97 1997 125 134
9. A.A. Brandes, M.K. Paris, and U. Basso Medulloblastomas: do molecular and biologic markers indicate different prognoses and treatments? Expert Rev. Anticancer Ther. 3 2003 615 620
10. J. Buhren, A.H. Christoph, R. Buslei, S. Albrecht, O.D. Wiestler, and T. Pietsch Expression of the neurotrophin receptor p75NTR in medulloblastomas is correlated with distinct histological and clinical features: evidence for a medulloblastoma subtype derived from the external granule cell layer J. Neuropathol. Exp. Neurol. 59 2000 229 240
11. A.R. Carter, E.M. Berry, and R.A. Segal Regional expression of p75NTR contributes to neurotrophin regulation of cerebellar patterning Mol. Cell Neurosci. 22 2003 1 13
12. A. Chakravarti, E. Noll, P.M. Black, D.F. Finkelstein, D.M. Finkelstein, N.J. Dyson, and J.S. Loeffler Quantitatively determined survivin expression levels are of prognostic value in human gliomas J. Clin. Oncol. 20 2002 1063 1068
13. A. Chopra, K.M. Brown, B.R. Rood, R.J. Packer, and T.J. MacDonald The use of gene expression analysis to gain insights into signaling mechanisms of metastatic medulloblastoma Pediatr. Neurosurg. 39 2003 68 74
14. D.W. Dawson, O.V. Volpert, P. Gillis, S.E. Crawford, H. Xu, W. Benedict, and N.P. Bouck Pigment epithelium-derived factor: a potent inhibitor of angiogenesis Science 285 1999 245 248
15. C.G. Eberhart, and P.C. Burger Anaplasia and grading in medulloblastomas Brain Pathol. 13 2003 376 385
16. R.A. Edelstein, R.J. Krane, R.K. Babayan, A. de las Morenas, and R.B. Moreland A rapid and simple method for the detection of prostate-specific antigen mRNA in archival tissue specimens using a reverse transcription- polymerase chain reaction assay Urology 45 1995 597 603
17. A. Fernandez-Teijeiro, R.A. Betensky, L.M. Sturla, J.Y. Kim, P. Tamayo, and S.L. Pomeroy Combining gene expression profiles and clinical parameters for risk stratification in medulloblastomas J. Clin. Oncol. 2004
18. P.G. Fisher, P.C. Burger, and C.G. Eberhart Biologic risk stratification of medulloblastoma: The real time is now J. Clin. Oncol. 2004
19. A. Gajjar, R. Hernan, M. Kocak, C. Fuller, Y. Lee, P.J. McKinnon, D. Wallace, C. Lau, M. Chintagumpala, D.M. Ashley, S.J. Kellie, L. Kun, and R.J. Gilbertson Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma J. Clin. Oncol. 2004
20. R. Gazit, V. Krizhanovsky, and N. Ben-Arie Math1 controls cerebellar granule cell differentiation by regulating multiple components of the Notch signaling pathway Development 131 2004 903 913
21. F. Giangaspero, G. Perilongo, M.P. Fondelli, M. Brisigotti, C. Carollo, R. Burnelli, P.C. Burger, and M.L. Garre Medulloblastoma with extensive nodularity: a variant with favorable prognosis J. Neurosurg. 91 1999 971 977
22. F. Giangaspero, L. Rigobello, M. Badiali, M. Loda, L. Andreini, G. Basso, F. Zorzi, and A. Montaldi Large-cell medulloblastomas. A distinct variant with highly aggressive behavior Am. J. Surg. Pathol. 16 1992 687 693
23. R. Gilbertson, C. Wickramasinghe, R. Hernan, V. Balaji, D. Hunt, D. Jones-Wallace, J. Crolla, R. Perry, J. Lunec, A. Pearson, and D. Ellison Clinical and molecular stratification of disease risk in medulloblastoma Br. J. Cancer. 85 2001 705 712
24. M.T. Giordana, P. Cavalla, A. Dutto, L. Borsotti, A. Chio, and D. Schiffer Is medulloblastoma the same tumor in children and adults? J. Neurooncol. 35 1997 169 176
25. D. Goldowitz, and K. Hamre The cells and molecules that make a cerebellum Trends Neurosci. 21 1998 375 382
26. M.A. Grotzer, M.D. Hogarty, A.J. Janss, X. Liu, H. Zhao, A. Eggert, L.N. Sutton, L.B. Rorke, G.M. Brodeur, and P.C. Phillips MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma Clin. Cancer Res. 2001 7
27. M.A. Grotzer, A.J. Janss, K. Fung, J.A. Biegel, L.N. Sutton, L.B. Rorke, H. Zhao, A. Cnaan, P.C. Phillips, V.M. Lee, and J.Q. Trojanowski TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors J. Clin. Oncol. 18 2000 1027 1035
28. M. Guan, H.F. Yam, B. Su, K.P. Chan, C.P. Pang, W.W. Liu, W.Z. Zhang, and Y. Lu Loss of pigment epithelium derived factor expression in glioma progression J. Clin. Pathol. 56 2003 277 282
29. A.W. Helms, K. Gowan, A. Abney, T. Savage, and J.E. Johnson Overexpression of MATH1 disrupts the coordination of neural differentiation in cerebellum development Mol. Cell Neurosci. 17 2001 671 682
30. J. Herms, I. Neidt, B. Luscher, A. Sommer, P. Schurmann, T. Schroder, M. Bergmann, B. Wilken, S. Probst-Cousin, P. Hernaiz-Driever, J. Behnke, F. Hanefeld, T. Pietsch, and H.A. Kretzschmar C-MYC expression in medulloblastoma and its prognostic value Int. J. Cancer. 89 2000 395 402
31. H. Huber, A. Eggert, A.J. Janss, R. Wiewrodt, H. Zhao, L.N. Sutton, L.B. Rorke, P.C. Phillips, and M.A. Grotzer Angiogenic profile of childhood primitive neuroectodermal brain tumours/medulloblastomas Eur. J. Cancer. 37 2001 2064 2072
32. C.D. Katsetos, L. Del Valle, A. Legido, J.P. de Chadarevian, E. Perentes, and S.J. Mork On the neuronal/neuroblastic nature of medulloblastomas: a tribute to Pio del Rio Hortega and Moises Polak Acta Neuropathol. (Berl.) 105 2003 1 13
33. C.D. Katsetos, A. Frankfurter, S. Christakos, E.L. Mancall, I.N. Vlachos, and H. Urich Differential localization of class III, beta-tubulin isotype and calbindin-D28k defines distinct neuronal types in the developing human cerebellar cortex J. Neuropathol. Exp. Neurol. 52 1993 655 666
34. C.D. Katsetos, M.M. Herman, L. Krishna, J.R. Vender, S.A. Vinores, D.P. Agamanolis, D. Schiffer, P.C. Burger, and H. Urich Calbindin-D28k in subsets of medulloblastomas and in the human medulloblastoma cell line D283 Med Arch. Pathol. Lab. Med. 119 1995 734 743
35. J.Y. Kim, M.E. Sutton, D.J. Lu, T.A. Cho, L.C. Goumnerova, L. Goritchenko, J.R. Kaufman, K.K. Lam, A.L. Billet, N.J. Tarbell, J. Wu, J.C. Allen, C.D. Stiles, R.A. Segal, and S.L. Pomeroy Activation of neurotrophin-3 receptor TrkC induces apoptosis in medulloblastomas Cancer Res. 59 1999 711 719
36. P. Kleihues, D.N. Louis, B.W. Scheithauer, L.B. Rorke, G. Reifenberger, P.C. Burger, and W.K. Cavenee The WHO classification of tumors of the nervous system J. Neuropathol. Exp. Neurol. 61 2002 215 225 (discussion 226-229)
37. Y. Lee, H.L. Miller, P. Jensen, R. Hernan, M. Connelly, C. Wetmore, F. Zindy, M.F. Roussel, T. Curran, R.J. Gilbertson, and P.J. McKinnon A molecular fingerprint for medulloblastoma Cancer Res. 63 2003 5428 5437
38. N. Ogata, L. Wang, N. Jo, J. Tombran-Tink, K. Takahashi, D. Mrazek, and M. Matsumura Pigment epithelium derived factor as a neuroprotective agent against ischemic retinal injury Curr. Eye Res. 22 2001 245 252
39. S.L. Pomeroy, M.E. Sutton, L.C. Goumnerova, and R.A. Segal Neurotrophins in cerebellar granule cell development and medulloblastoma J. Neurooncol. 35 1997 347 352
40. S.L. Pomeroy, P. Tamayo, M. Gaasenbeek, L.M. Sturla, M. Angelo, M.E. McLaughlin, J.Y. Kim, L.C. Goumnerova, P.M. Black, C. Lau, J.C. Allen, D. Zagzag, J.M. Olson, T. Curran, C. Wetmore, J.A. Biegel, T. Poggio, S. Mukherjee, R. Rifkin, A. Califano, G. Stolovitzky, D.N. Louis, J.P. Mesirov, E.S. Lander, and T.R. Golub Prediction of central nervous system embryonal tumour outcome based on gene expression Nature 415 2002 436 442
41. C. Sarkar, P. Pramanik, A.K. Karak, P. Mukhopadhyay, M.C. Sharma, V.P. Singh, and V.S. Mehta Are childhood and adult medulloblastomas different? A comparative study of clinicopathological features, proliferation index and apoptotic index J. Neurooncol. 59 2002 49 61
42. T. Sasaki, M.B. Lopes, G.R. Hankins, and G.A. Helm Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system Acta Neuropathol. (Berl.) 104 2002 105 109
43. R.A. Segal, L.C. Goumnerova, Y.K. Kwon, C.D. Stiles, and S.L. Pomeroy Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma Proc. Natl. Acad. Sci. U.S.A. 91 1994 12867 12871
44. I. Slavc, I.R. Rodriguez, K. Mazuruk, G.J. Chader, and J.A. Biegel Mutation analysis and loss of heterozygosity of PEDF in central nervous system primitive neuroectodermal tumors Int. J. Cancer. 72 1997 277 282
45. T. Taniwaki, S.P. Becerra, G.J. Chader, and J.P. Schwartz Pigment epithelium-derived factor is a survival factor for cerebellar granule cells in culture J. Neurochem. 64 1995 2509 2517
46. T. Taniwaki, N. Hirashima, S.P. Becerra, G.J. Chader, R. Etcheberrigaray, and J.P. Schwartz Pigment epithelium-derived factor protects cultured cerebellar granule cells against glutamate-induced neurotoxicity J. Neurochem. 68 1997 26 32
47. J. Tombran-Tink, and C.J. Barnstable PEDF: a multifaceted neurotrophic factor Nat. Rev. Neurosci. 4 2003 628 636
48. J. Tombran-Tink, and C.J. Barnstable Therapeutic prospects for PEDF: more than a promising angiogenesis inhibitor Trends Mol. Med. 9 2003 244 250
49. J. Tombran-Tink, H. Pawar, A. Swaroop, I. Rodriguez, and G.J. Chader Localization of the gene for pigment epithelium-derived factor (PEDF) to chromosome 17p13.1 and expression in cultured human retinoblastoma cells Genomics 19 1994 266 272
50. W.M. Tong, H. Ohgaki, H. Huang, C. Granier, P. Kleihues, and Z.Q. Wang Null mutation of DNA strand break-binding molecule poly(ADP-ribose) polymerase causes medulloblastomas in p53(-/-) mice Am. J. Pathol. 162 2003 343 352
51. D.T. Yew, C.B. Luo, C.W. Heizmann, and W.Y. Chan Differential expression of calretinin, calbindin D28K and parvalbumin in the developing human cerebellum Brain Res. Dev. Brain Res. 103 1997 37 45
52. N. Yokota, J. Aruga, S. Takai, K. Yamada, M. Hamazaki, T. Iwase, H. Sugimura, and K. Mikoshiba Predominant expression of human zic in cerebellar granule cell lineage and medulloblastoma Cancer Res. 56 1996 377 383
53. P.M. Zeltzer, J.M. Boyett, J.L. Finlay, A.L. Albright, L.B. Rorke, J.M. Milstein, J.C. Allen, K.R. Stevens, P. Stanley, H. Li, J.H. Wisoff, J.R. Geyer, P. McGuire-Cullen, J.A. Stehbens, S.B. Shurin, and R.J. Packer Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study J. Clin. Oncol. 17 1999 832 845